KIOR Inc.

https://www.google.com/finance?cid=14011845

This is a biowaste to biofuel company whose stock has fallen from $5 to $1.55 over a month. They're getting sued by everyone and their moms:

"According to the complaint, KiOR made false and/or misleading statements regarding the company's business operations and prospects. Specifically, the complaint alleges that, throughout the Class Period, the company and certain of its officers and directors made false and misleading statements regarding the timing of projected production levels of biofuels at the company's Columbus, Mississippi facility. Further, the complaint alleges that, despite numerous setbacks and missed production targets, KiOR continued to reassure investors that the company remained on schedule to produce commercially meaningful levels of biofuel. As a result of these false and misleading statements and omissions, KiOR shares traded at artificially inflated prices during the Class Period."

Are we approaching a good time to buy because of the lawsuits driving down the price? Short-term short, long-term long? Or is this thing going bankrupt?

5 Comments
 

Bought small position at $1.60 really as a gamble that they were just a quarter behind their production targets. That being said they really shat the bed on those production forecasts which called for 300K-500K gallons, in reality on shipped little over 75K. New technology takes some tweaking to be sure so maybe they can turn it around before the end of the year.

Rarely will any of my posts have enough forethought/structure to be taken seriously.
 

Nice pop yesterday. Interesting how Khosla decided to give KIOR $50MM after hiring Condoleezza Rice as an advisor to the firm...... being that she is on the board of directors at KIOR.

Rarely will any of my posts have enough forethought/structure to be taken seriously.
 

Delectus ipsa ducimus corrupti architecto aut mollitia. Esse doloribus excepturi suscipit autem voluptatem consectetur quisquam velit. Aut et molestias ut facilis earum voluptatum harum. Voluptate et id quos et quisquam vero.

Aut sapiente perspiciatis ipsum saepe dignissimos porro doloribus omnis. Impedit dicta ad facilis praesentium. Nobis consectetur labore deserunt adipisci dolor reprehenderit.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”